Table 1.
Patient characteristics.
| Characteristic | No apparent retinopathy | Mild NPDR | Moderate NPDR | Severe NPDR | PDR |
|---|---|---|---|---|---|
| Eyes/patients | 11/6 | 8/5 | 47/31 | 15/11 | 27/17 |
| Age (years) | 64.8 ± 11.7 | 71.5 ± 19.6 | 67.1 ± 10.9 | 60.7 ± 9.8 | 52.9 ± 12.4 |
| Men/women | 5/1 | 3/2 | 24/7 | 9/2 | 12/5 |
| Diabetes duration (years) | 13.7 ± 2.3 | 13.0 ± 2.9 | 9.8 ± 6.9 | 14.2 ± 7.4 | 9.8 ± 8.1 |
| HbA1c (%) | 7.33 ± 1.91 | 6.75 ± 0.35 | 7.61 ± 1.77 | 7.54 ± 0.78 | 7.57 ± 1.38 |
| Systemic hypertension (present/absent) | 2/4 | 5/0 | 18/13 | 7/4 | 11/6 |
| Dyslipidemia (present/absent) | 1/5 | 2/3 | 10/21 | 3/8 | 4/13 |
| LogMAR VA | −0.033 ± 0.175 | 0.095 ± 0.212 | 0.038 ± 0.159 | 0.068 ± 0.184 | 0.104 ± 0.258 |
| Center-involved DME | — | 4 eyes | 14 eyes | 10 eyes | 11 eyes |
| Ischemic maculopathy | — | 0 eye | 0 eye | 6 eyes | 6 eyes |
| CSF thickness (µm) | 244 ± 36 | 290 ± 58 | 284 ± 61 | 346 ± 69 | 325 ± 120 |
| SSI | 70.8 ± 4.9 | 68.5 ± 5.8 | 67.3 ± 5.4 | 66.2 ± 4.7 | 70.0 ± 6.6 |